Supporting the hypothesis that increased ROS plays a significant role in depression, Mellon et al. reported that genes regulated by Nrf-2 were elevated in MDD patients and decreased after effective antidepressant treatment [158]. This evidence concerns the gene NFE2L2 and depressive symptom measurement.